Abstract
Macromolecular drugs become an essential part in neuroprotective treatment. However, the nature of ineffective delivery crossing the blood brain barrier (BBB) renders those macromolecules undruggable for clinical practice. Recently, brain target via intranasal delivery have provided a promising solution to circumventing the BBB. Despite the direct route from nose to brain (i.e. olfactory pathway), there still are big challenges for large compounds like proteins to overcome the multiple delivery barriers such as nasal mucosa penetration, intracellular transport along the olfactory neuron, and diffusion across the heterogeneous brain compartments. Herein presented is an intranasal strategy mediated by cell-penetrating peptide modified poly(lactic-co-glycolic acid) (PLGA) nanoparticles for the delivery of insulin to the brain, a potent therapeutic against Alzheimer’s disease. The results revealed that the cell-penetrating peptide can potentially deliver insulin into brain via the nasal route, showing a total brain delivery efficiency of 6%. It could serve as a potential treatment for neurodegenerative diseases.
Article PDF
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
References
L. T. Loftus, H. F. Li, A. J. Gray, C. Hirata-Fukae, B. A. Stoica, J. Futami, H. Yamada, P. S. Aisen, and Y. Matsuoka, Neuroscience, 139, 1061 (2006).
J. D. Suman, Expert Opin. Biol. Ther., 3, 519 (2003).
Y. Huang, Y. S. Park, J. Wang, C. Moon, Y. M. Kwon, H. S. Chung, Y. J. Park, and V. C. Yang, Curr. Pharm. Des., 16, 2369 (2010).
U. Langel, Cell-Penetrating Peptides, Springer, New York, 2010.
J. H. Liu, Y. X. Zhao, Q. Q. Guo, Z. Wang, H. Y. Wang, Y. X. Yang, and Y. Z. Huang, Biomaterials, 33, 6155 (2012).
Y.-H. Wang, C.-P. Chen, M.-H. Chan, M. Chang, Y.-W. Hou, H.-H. Chen, H.-R. Hsu, K. Liu, and H.-J. Lee, Biochem. Biophys. Res. Commun., 346, 758 (2006).
Y.-W. Hou, M.-H. Chan, H.-R. Hsu, B. R. Liu, C.-P. Chen, H.-H. Chen, and H.-J. Lee, Experimental Dermatology, 16, 999 (2007).
E. Cohen and A. Dillin, Nat. Rev. Neurosci., 9, 759 (2008).
Z. Laron, Arch. Physiol. Biochem., 115, 112 (2009).
S. Craft, L. D. Baker, T. J. Montine, S. Minoshima, G. S. Watson, A. Claxton, M. Arbuckle, M. Callaghan, E. Tsai, S. R. Plymate, P. S. Green, J. Leverenz, D. Cross, and B. Gerton, Arch. Neurol., 69, 29 (2012).
C. E. Astete and C. M. Sabliov, J. Biomater. Sci. Polym. Ed., 17, 247 (2006).
R. Yang, W. S. Shim, F. D. Cui, G. Cheng, X. Han, Q. R. Jin, D. D. Kim, S. J. Chung, and C. K. Shim, Int. J. Pharm., 371, 142 (2009).
G. F. Liang, Y. L. Zhu, B. Sun, F. H. Hu, T. Tian, S. C. Li, and Z. D. Xiao, Nanoscale Res. Lett., 6, 447 (2011).
S. H. Kim, J. H. Jeong, K. W. Chun, and T. G. Park, Langmuir, 21, 8852 (2005).
V. P. Torchilin, Adv. Drug Deliv. Rev., 60, 548 (2008).
G. Ruan, A. Agrawal, A. I. Marcus, and S. Nie, J. Am. Chem. Soc., 129, 14759 (2007).
A. Som, A. O. Tezgel, G. J. Gabriel, and G. N. Tew, Angew. Chem. Int. Ed. Engl., 50, 6147 (2011).
Q. Cai, G. Shi, J. Bei, and S. Wang, Biomaterials, 24, 629 (2003).
H. Pan, H. Jiang, and W. Chen, Biomaterials, 29, 1583 (2008).
S. R. Schwarze, A. Ho, A. Vocero-Akbani, and S. F. Dowdy, Science, 285, 1569 (1999).
G. P. Dietz and M. Bahr, Brain Res. Bull., 68, 103 (2005).
H. He, A. David, J. Zhang, Y. Park, J. Wang, Y. Huang, J. Wang, and V. Yang, Macromol. Res., 19, 1224 (2011).
J. F. Liang and V. C. Yang, Biochem. Biophys. Res. Commun., 335, 734 (2005).
R. C. Mundargi, V. R. Babu, V. Rangaswamy, P. Patel, and T. M. Aminabhavi, J. Control. Release, 125, 193 (2008).
Z. Wen, Z. Yan, R. He, Z. Pang, L. Guo, Y. Qian, X. Jiang, and L. Fang, Drug Deliv., 18, 555 (2011).
B. Semete, L. Booysen, Y. Lemmer, L. Kalombo, L. Katata, J. Verschoor, and H. S. Swai, Nanomedicine, 6, 662 (2010).
Author information
Authors and Affiliations
Corresponding author
Additional information
Equal contribution.
Rights and permissions
About this article
Cite this article
Yan, L., Wang, H., Jiang, Y. et al. Cell-penetrating peptide-modified PLGA nanoparticles for enhanced nose-to-brain macromolecular delivery. Macromol. Res. 21, 435–441 (2013). https://doi.org/10.1007/s13233-013-1029-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13233-013-1029-2